anti- Carboxypeptidase B2 antibody

Carboxypeptidase B2 (CPB2), also known as thrombin-activable fibrinolysis inhibitor (TAFI), is an enzyme involved in regulating blood clotting and fibrinolysis. Our Anti-Carboxypeptidase B2 Antibody, available in a 100µg vial, is a vital tool for investigating the functions of CPB2 in coagulation and its implications in hemostasis and thrombosis research.

CPB2 plays a pivotal role in preventing excessive fibrinolysis by cleaving C-terminal lysine and arginine residues from fibrin, thereby stabilizing blood clots. This highly specific antibody is meticulously developed and rigorously validated to ensure accurate and reproducible results in your research. It is suitable for various applications, including Western blotting, immunohistochemistry, and enzyme activity assays.

With our Anti-Carboxypeptidase B2 Antibody, you can explore CPB2's roles in hemostasis, thrombosis, and its potential involvement in bleeding and clotting disorders. This versatile research tool empowers you to advance your understanding of CPB2 and its significance in coagulation biology.

The 100µg vial size provides an ample supply of antibody for multiple experiments, ensuring cost-effectiveness and flexibility in your research endeavors. Dive into the intricate world of CPB2 and its impact on blood clotting and fibrinolysis with precision and reliability using our high-quality antibody.